Publication
Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Journal Paper/Review - Oct 3, 2024
Arber Caroline, Baerlocher Gabriela M, Chalandon Yves, Daskalakis Michael, Duchosal Michel A, Fehr Martin, Gerull Sabine, Güngör Tayfun, Nair Gayathri, Pabst Thomas, Passweg Jakob R, Piccolruaz Barbara, Renner Christoph, Rüfer Axel, Schneidawind Dominik, Stuessi Georg, Zeerleder Sacha, Halter Jörg P, Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group
Units
PubMed
Doi
Contact
Citation
Arber C, Baerlocher G, Chalandon Y, Daskalakis M, Duchosal M, Fehr M, Gerull S, Güngör T, Nair G, Pabst T, Passweg J, Piccolruaz B, Renner C, Rüfer A, Schneidawind D, Stuessi G, Zeerleder S, Halter J, Swiss Blood Stem Cell Transplant and Cellular Therapies (SBST) group. Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Med Wkly 2024; 154:3704.
Type
Journal Paper/Review (English)
Journal
Swiss Med Wkly 2024; 154
Publication Date
Oct 3, 2024
Issn Electronic
1424-3997
Pages
3704